Capital Research Global Investors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Capital Research Global Investors's RMD Position: Q1 2023 in Review
Capital Research Global Investors sold out of ResMed (RMD) in Q1 2023, closing a stake of 420,868 shares — an estimated $87.6M sold.
Capital Research Global Investors first reported a position in RMD in Q2 2013 and held it in 17 quarters. The position peaked at $688M in Q1 2015. 677 funds tracked by Wall St. Rank hold RMD as of Q1 2023.
- Capital Research Global Investors reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
- Capital Research Global Investors sold 420,868 ResMed shares in Q1 2023, an estimated $87.6M.
- Capital Research Global Investors first reported a position in ResMed in Q2 2013 and held it in 17 quarters.
- Capital Research Global Investors's ResMed position peaked at $688M in Q1 2015.
- 677 funds tracked by Wall St. Rank held ResMed as of Q1 2023.
Based on Capital Research Global Investors's 13F filing for Q1 2023, filed 15 May 2023.